Also trades as: CTCXW (NASDAQ) · $vol 0M
CTCX NASDAQ
Carmell Therapeutics Corporation
1W: -4.9%
1M: -39.9%
3M: -83.1%
1Y: -95.5%
3Y: -98.8%
$0.20
Last traded 2025-04-04 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2M
Revenue
+60.3% YoY
$-7M
Net Income
+5.0% YoY
$-2M
Free Cash Flow
+34.5% YoY
59.5%
Gross Margin
-182.9%
Op. Margin
-475.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE109.8%
ROA-286.0%
ROIC54.0%
Valuation
P/E-0.0
P/B-0.1
EV/EBITDA-0.1
Leverage
Debt/Equity-0.03
Current Ratio0.07
Interest Cov.-127.9x
Quality Scores
Piotroski F2/9
Altman Z-117.87
Beneish M-22.69